Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 19OTHER_GOV 3NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Gastrointestinal 1

Conditions

Colorectal Neoplasms 1458Pancreatic Neoplasms 831Stomach Neoplasms 692Carcinoma, Hepatocellular 647Carcinoma, Non-Small-Cell Lung 538Neoplasms 459Breast Neoplasms 369Ovarian Neoplasms 338Neoplasm Metastasis 335Colonic Neoplasms 331Esophageal Neoplasms 297Liver Neoplasms 265Melanoma 255Lung Neoplasms 245Squamous Cell Carcinoma of Head and Neck 209Carcinoma, Renal Cell 180Cholangiocarcinoma 179Prostatic Neoplasms 174Head and Neck Neoplasms 172Triple Negative Breast Neoplasms 161Endometrial Neoplasms 160Rectal Neoplasms 159Uterine Cervical Neoplasms 154Gastrointestinal Neoplasms 142Urinary Bladder Neoplasms 139Biliary Tract Neoplasms 135Gastrointestinal Stromal Tumors 108Sarcoma 104Esophageal Squamous Cell Carcinoma 101Small Cell Lung Carcinoma 94

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Deglutition Disorders × Gastrointestinal × Clear all
NCT02159898 2018-06-07

EndoMAXX Endoluminal Valve Technology (EVT) Compared to EndoMAXX

Merit Medical Systems, Inc.

Phase NA Completed
60 enrolled 9 charts
Gastrointestinal

Deglutition Disorders, Esophageal Neoplasms, Gastroesophageal Reflux

Data powered by HemOnc (CC BY 4.0) Colophon âš¡